| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/07/2009 | EP2011787A1 Dying composition comprising an azomethin-type compound with a pyrazolinone moiety |
| 01/07/2009 | EP2011499A2 Pyrrolo[2,3d]Pyrimidine compositions and their use |
| 01/07/2009 | EP2010542A2 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders |
| 01/07/2009 | EP2010538A1 PROCESS FOR THE PREPARATION OF Ý(1R), 2S¨-2-AMINOPROPIONIC ACID 2-Ý4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLOÝ2,1-f¨Ý1,2,4¨TRIAZIN-6-YLOXY¨-1-METHYLETHYL ESTER |
| 01/07/2009 | EP2010537A1 Imidazoquinoxaline compounds as immunomodulators |
| 01/07/2009 | EP2010536A1 Imidazo [1, 2-b]pyridazines, their processes of preparation and their use as gaba receptor ligands |
| 01/07/2009 | EP2010172A2 Indoles and benzoimidazoles as modulators of the histamine h4 receptor |
| 01/07/2009 | EP1562589B1 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/07/2009 | CN101341151A Diazepinones |
| 01/07/2009 | CN101341150A Nitroimidazole compounds |
| 01/07/2009 | CN101341138A Cyclic anilino-pyridinotriazines as GSK-3 inhibitors |
| 01/07/2009 | CN101341134A 嘧啶衍生物 Pyrimidine derivatives |
| 01/07/2009 | CN101337964A Swine blood bovine and method for preparing same |
| 01/07/2009 | CN101337963A Preparation of metal deuteroporphyrin compounds and method of use thereof |
| 01/07/2009 | CN100448876C Heterocyclocarboxamide derivatives |
| 01/07/2009 | CN100448870C 2-aminoquinoline derivative |
| 01/07/2009 | CN100448868C Tri-substituted heteroaryls and methods of making and using the same |
| 01/06/2009 | US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 01/06/2009 | US7473782 Fluorinated dyes or colorants and their uses |
| 01/06/2009 | US7473694 excellent inhibitory activity against MAPKAP-K2; inflammatory disorder, autoimmune diseases, destructive osteopathy, cancer and/or tumor growth; (4-ethoxyphenyl)(5-piperidin-3-yl-6,7-dihydro-5H-1,4,5,8a-tetraaza-s-indacen-8-yl)amine |
| 01/06/2009 | US7473691 Pyrazole compounds useful as protein kinase inhibitors |
| 01/06/2009 | US7473689 Short-acting benzodiazepines |
| 01/06/2009 | CA2227851C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 01/01/2009 | US20090005575 Preparation of diazapentalene derivatives via epoxydation of dihydropyrroles |
| 01/01/2009 | US20090005559 A2a receptor antagonists useful in treatment of central nervous system diseases in particular Parkinson's disease |
| 01/01/2009 | US20090005556 Process for Producing Pure Form of 2-Methyl-4-(4-Methyl-1-Piperazinyl)-10H-Thieno[2,3-b] [1,5]Benzodiazepine |
| 01/01/2009 | US20090005555 Titanyl phthalocyanine processes and photoconductors thereof |
| 01/01/2009 | US20090005412 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/01/2009 | US20090005402 Medicine containing pyrimidine derivative |
| 01/01/2009 | US20090005395 Sildenafil n-oxide as prodrug |
| 01/01/2009 | US20090005390 Novel quinuclidine derivatives and their use |
| 01/01/2009 | US20090005389 2,5 Diaza-Bicyclo [2.2.1] Heptane Derivatives as Calcium Channel Blockers |
| 01/01/2009 | US20090005372 Cyclopropanecarboxylic acid {4-[3-(4-methoxy-phenyl)-[1,2,4]triazolo[3,4-a]phthalazin-6-ylamino]-phenyl}-amide; phosphodiesterase inhibitors; neoangiogenesis or inflammatory disease |
| 01/01/2009 | US20090005359 Heterocyclic Compounds Useful as RAF Kinase Inhibitors |
| 01/01/2009 | US20090001880 Organic electroluminescent device, an azepine compound, and a method for making the same |
| 01/01/2009 | US20090001354 Heterocycloalkyl-substituted naphthalene-based tetracarboxylic diimide compounds as n-type semiconductor materials for thin film transistors |
| 12/31/2008 | WO2009002807A2 Indolyl pyrrolidines for the treatment of cancer |
| 12/31/2008 | WO2009002552A1 Racemization process of r-zopiclone |
| 12/31/2008 | WO2009001128A1 1,2-cycl0hexane dicarboxamides as cathepsin inhibitors |
| 12/31/2008 | WO2009000818A1 3-carbonylaminothiophene-2-carboxylic acids as hepatitis c virus inhibitors |
| 12/31/2008 | WO2009000798A1 Sildenafil n-oxide as prodrug |
| 12/31/2008 | WO2009000757A1 Piperazine compounds with herbicidal action |
| 12/31/2008 | WO2009000753A1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres |
| 12/31/2008 | WO2009000663A1 Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors |
| 12/31/2008 | WO2009000412A1 A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles |
| 12/31/2008 | WO2009000237A1 Use of a precursor of an n-dopant for doping an organic semiconductive material, precursor and electronic or optoelectronic component |
| 12/31/2008 | WO2009000163A1 1β- METHYLCARBAPENEM ANTIBIOTICS,THE PHARMACEUTICAL COMPOSITION AND USE THEREOF |
| 12/31/2008 | WO2008128072A3 Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders |
| 12/31/2008 | WO2008082487A3 Novel jnk inhibitors |
| 12/31/2008 | WO2008053221A3 Process for preparing indol- 5 -oxy- quinazoline derivatives and intermediates |
| 12/31/2008 | WO2008040995A9 Indazoles for use as dpp-iv inhibitors |
| 12/31/2008 | EP2009014A1 Application of a precursor of an n-dopant for doping an organic semi-conducting material, precursor and electronic or optoelectronic component |
| 12/31/2008 | EP2009005A1 Azolecarboxamide derivative |
| 12/31/2008 | EP2008210A1 Modulation of phosphoryl transferase activity of glutamine synthetase |
| 12/31/2008 | EP2007789A2 Hcv/hiv inhibitors and their uses |
| 12/31/2008 | EP2007768A2 Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone |
| 12/31/2008 | EP2007767A1 Pyrrolopyrimidine derivatives used as hsp90 inhibitors |
| 12/31/2008 | EP2007754A1 2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer |
| 12/31/2008 | EP2007725A2 Non-peptidic renin inhibitors nitroderivatives |
| 12/31/2008 | EP1737863B1 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors |
| 12/31/2008 | EP1678181B1 A2b adenosine receptor antagonists |
| 12/31/2008 | EP1435785B1 Iminobenzoxazines, iminobenzothiazines and iminoquinazolines for controlling invertebrate pests |
| 12/31/2008 | EP1424942B1 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy |
| 12/31/2008 | EP1392261B1 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 12/31/2008 | CN101336244A 9-membered heterobicyclic compounds as inhibitors of protein kinases |
| 12/31/2008 | CN101333221A Stabilization method for annular L-proline anhydride configuration |
| 12/31/2008 | CN101333220A Method for synthesizing benzo [4,5]glyoxalino [1,2-alpha]miazine derivates |
| 12/31/2008 | CN101333173A N-[4-(butanal-4-group)-benzoyl]-L-glutamic acid dimethyl ester compound and method for preparing pemetrexed by using the compounds |
| 12/31/2008 | CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 12/31/2008 | CA2693142A1 A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles |
| 12/31/2008 | CA2692182A1 Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors |
| 12/31/2008 | CA2690782A1 Compositions and methods for treatment of cancer |
| 12/31/2008 | CA2690294A1 Sildenafil n-oxide as prodrug |
| 12/31/2008 | CA2686224A1 Piperazine compounds having herbicidal action |
| 12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 12/30/2008 | US7470797 Nuclear hormone receptor modulator; anticarcinogenic agent; 3-(4-Cyano-3-trifluoromethylphenylcarbamoyl containing 3-carboxy-14-dimethyl-5-oxa-7-oxybicyclo(2.2.2) heptane compound |
| 12/30/2008 | US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions |
| 12/30/2008 | US7470705 e.g. Cis-4-[acety1-(3,5-bis-trifluoromethyl-benzyl)-amino]-2-ethyl-6-methoxy-3,4-dihydro-2H- [1,5]naphthyridine-1-carboxylic acid isopropyl ester; cholesterol ester transfer protein (CETP) inhibitors; increasing plasma HDL- cholesterol, decreasing plasma LDL- cholesterol; atherosclerosis |
| 12/30/2008 | US7470698 Adenosine A3 receptor modulators |
| 12/30/2008 | US7470697 E.g.,1-(2-(dimethylamino)ethyl)-3-(4-fluorophenyl)-1-(5-(2,3,4,5-tetrahydro-2,4-dioxo-1,3-dipropyl-1H-pyrrolo[3,2-d]pyrimidin-6-yl)pyridin-2-yl)urea; antidiarrhea and -ischemic agents; antidiabetic agents/insulin-resistance; asthma; antiallergens; obesity; autoimmune diseases; reperfusion injuries |
| 12/30/2008 | US7470696 Tyrosine kinase inhibitors |
| 12/30/2008 | US7470695 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 12/30/2008 | US7470689 6-chloro-4-(3H-imidazo[4,5-c]pyridin-2-yl)-2H-pyridazin-3-one and and 4-(3H-imidazol [4,5-c]pyridin-2-yl)-6-pyridin-4-yl-2H-pyridazin-3-one; cyclin-dependent kinase inhibitor; anticarcinogenic, antitumor agent |
| 12/30/2008 | US7470688 Phthalazinone derivatives |
| 12/30/2008 | US7470680 4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid (9-benzyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(R)-cyclohepta[e]inden-7-yl)-amide; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, menopause, asthma |
| 12/30/2008 | US7470679 Constrained compounds as CGRP-receptor antagonists |
| 12/30/2008 | US7470677 Oxidant scavengers |
| 12/30/2008 | US7470315 Ink jet inks with near-infrared dyeshaving greater functionality, improved water solubility or inhibited intermolecular interactions; invisible bar codes for security tagging |
| 12/30/2008 | CA2446903C Imidazo ¬1,5-a| pyrimido ¬5,4-d| benzazepine derivatives as gaba a receptor modulators |
| 12/30/2008 | CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 12/25/2008 | US20080319192 New dihydropteridione derivatives, process for their manufacture and their use as medicament |
| 12/25/2008 | US20080319190 New dihydropteridione derivatives, process for their manufacture and their use as medicament |
| 12/25/2008 | US20080319187 New water soluble porphylleren compounds |
| 12/25/2008 | US20080318980 USE OF 7-(PYRIMIDIN-4 YL)-IMIDAZO[1,2-a]PYRIMIDIN-5(1H)-ONES AS GSK-3BETA INHIBITORS |
| 12/25/2008 | US20080318964 Deuterium-enriched eszopiclone |
| 12/25/2008 | US20080318949 Pyrazolopyrimidinone Derivatives, Their Preparation And Their Use |
| 12/25/2008 | US20080318940 Quinazolinone Derivatives as Vanilloid Antagonists |
| 12/25/2008 | US20080318935 Substituted imidazoheterocycles |
| 12/25/2008 | US20080318934 Diazepinoes |
| 12/25/2008 | US20080318929 Pyrimidine Derivatives Useful as Inhibitors of Pkc-Theta |